ロード中...
Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication
We experienced two cases of dipeptidyl peptidase‐4 (DPP‐4) inhibitor‐associated bullous pemphigoid (BP) showing an unfavorable course despite its discontinuation. Clinicians should carefully monitor the course of DPP‐4 inhibitor‐associated BP even after withdrawal of DPP‐4 inhibitor therapy, especia...
保存先:
| 出版年: | Clin Case Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7562854/ https://ncbi.nlm.nih.gov/pubmed/33088540 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3047 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|